Change search
ReferencesLink to record
Permanent link

Direct link
PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo
Populat Council, NY 10021 USA.
Populat Council, NY 10021 USA.
Linköping University. Populat Council, NY 10021 USA.
Populat Council, NY 10021 USA.
Show others and affiliations
2016 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 11, no 9, e0161730Article in journal (Refereed) Published
Abstract [en]

Myeloid dendritic cells (mDCs) contribute to both HIV pathogenesis and elicitation of antiviral immunity. Understanding how mDC responses to stimuli shape HIV infection outcomes will inform HIV prevention and treatment strategies. The long double-stranded RNA (dsRNA) viral mimic, polyinosinic polycytidylic acid (polyIC, PIC) potently stimulates DCs to focus Th1 responses, triggers direct antiviral activity in vitro, and boosts anti-HIV responses in vivo. Stabilized polyICLC (PICLC) is being developed for vaccine adjuvant applications in humans, making it critical to understand how mDC sensing of PICLC influences HIV infection. Using the monocyte-derived DC (moDC) model, we sought to describe how PICLC (vs. other dsRNAs) impacts HIV infection within DCs and DC-T cell mixtures. We extended this work to in vivo macaque rectal transmission studies by administering PICLC with or before rectal SIVmac239 (SIVwt) or SIVmac239 Delta Nef (SIV Delta Nef) challenge. Like PIC, PICLC activated DCs and T cells, increased expression of alpha(4)beta(7) and CD169, and induced type IIFN responses in vitro. The type of dsRNA and timing of dsRNA exposure differentially impacted in vitro DC-driven HIV infection. Rectal PICLC treatment similarly induced DC and T cell activation and pro-and anti-HIV factors locally and systemically. Importantly, this did not enhance SIV transmission in vivo. Instead, SIV acquisition was marginally reduced after a single high dose challenge. Interestingly, in the PICLC-treated, SIV Delta Nef-infected animals, SIV Delta Nef viremia was higher, in line with the importance of DC and T cell activation in SIV Delta Nef replication. In the right combination anti-HIV strategy, PICLC has the potential to limit HIV infection and boost HIV immunity.

Place, publisher, year, edition, pages
PUBLIC LIBRARY SCIENCE , 2016. Vol. 11, no 9, e0161730
National Category
Immunology
Identifiers
URN: urn:nbn:se:liu:diva-132222DOI: 10.1371/journal.pone.0161730ISI: 000383255200023PubMedID: 27603520OAI: oai:DiVA.org:liu-132222DiVA: diva2:1039797
Note

Funding Agencies|National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R37 AI040877, R01 AI040877-19]; National Cancer Institute, NIH [HHSN261200800001E]; Tulane National Primate Research Center [P51OD011104]

Available from: 2016-10-25 Created: 2016-10-21 Last updated: 2016-11-15

Open Access in DiVA

fulltext(2233 kB)11 downloads
File information
File name FULLTEXT01.pdfFile size 2233 kBChecksum SHA-512
330509acd01950fb0f96318281703bcbb271be79724d86f3c14d6637cf7da596dbc8d89175d15d0184a1b5fad7c5c891ac0e31fc804085c1d71b5604f241929a
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hallor, Magnus
By organisation
Linköping University
In the same journal
PLoS ONE
Immunology

Search outside of DiVA

GoogleGoogle Scholar
Total: 11 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 37 hits
ReferencesLink to record
Permanent link

Direct link